Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Other(2)

Detailed Status

unknown2
Active, not recruiting1
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown240%
active_not_recruiting120%
completed120%
recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

NCT03412760
recruiting

Helix Research Network

NCT06057181
completednot_applicable

Hypospadias and Exome: Identification of New Genes for Familial Hypospadias

NCT02495090
unknown

Second Molecular Event Identification by Exome Sequencing for Intellectually Disabled Patients Carrying 16p13.11 CNVs

NCT03644797
unknown

Exome Analysis in Hearing Impaired Patients

NCT03557879

Clinical Trials (5)

Showing 5 of 5 trials
NCT03412760Not Applicable

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

Active Not Recruiting
NCT06057181

Helix Research Network

Recruiting
NCT02495090Not Applicable

Hypospadias and Exome: Identification of New Genes for Familial Hypospadias

Completed
NCT03644797

Second Molecular Event Identification by Exome Sequencing for Intellectually Disabled Patients Carrying 16p13.11 CNVs

Unknown
NCT03557879

Exome Analysis in Hearing Impaired Patients

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5